Synthesis, structure elucidation and antitumour activity of N-substituted amides of 3-(3-ethylthio-1,2,4-triazol-5-yl)propenoic acid

European Journal of Medicinal Chemistry

Volumn 44, Issue 9, 2009, Pages 3788-3793

  Pachuta Stec, Anna ^a   Rzymowska, Jolanta ^a   Mazur, Liliana ^b   Mendyk, Ewaryst ^b   Pitucha, Monika ^a   Rzaczyńska, Zofia ^b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b MARIA CURIE SK ODOWSKA UNIVERSITY   (Poland)

Author keywords

1,2,4 Triazole; Anticancer activity; N Substituted amides; X ray crystal structure analysis

Indexed keywords

3 (3 ETHYLTHIO 1,2,4 TRIAZOL 5 YL)PROPENOIC ACID DERIVATIVE; AMIDE; S ETHYL 7 OXABICYCLO[2.2.1]HEPT 5 ENE 2,3 DICARBONYL ISOTHIOSEMICARBAZIDE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER CELL CULTURE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; IC 50; LUNG CARCINOMA; PROTON NUCLEAR MAGNETIC RESONANCE; SKIN FIBROBLAST; X RAY CRYSTALLOGRAPHY;

AMIDES; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; CARCINOMA; CELL LINE; CELL LINE, TUMOR; CELL PROLIFERATION; CRYSTALLOGRAPHY, X-RAY; FEMALE; FIBROBLASTS; HUMANS; LUNG NEOPLASMS; SKIN; TRIAZOLES;

EID: 67650453403     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2009.04.034     Document Type: Article

References (28)

1. Zitoui G.T., Kaplancikli Z.A., Yildiz M.T., Chevallet P., and Kaya D. Eur. J. Med. Chem. 40 (2005) 607-613
2. Sheehan D.J., Hitchcock C.A., and Sibley C.M. Clin. Microbiol. Rev. 12 (1999) 40-79
3. Demirbas N., Karaoglu S.A., Demirbas A., and Sancak K. Eur. J. Med. Chem. 39 (2004) 793-804
4. Vicini P., Geronikaki A., Incerti M., Busonera B., Poni G., Cabras C.A., and Colla P.L. Bioorg. Med. Chem. 11 (2003) 4785-4789
5. Amir M., and Shikha K. Eur. J. Med. Chem. 39 (2004) 535-545
6. Labanauskas L., Udrenaite E., Gaidelis P., and Brukstus A. Il Farmaco 59 (2004) 255-259
7. Labanauskas L., Kalcas V., Udrenaite E., Gaidelis P., Brukstus A., and Dauksas V. Pharmazie 56 (2001) 617-619
8. Chiu S.H.L., and Huskey S.E.W. Drug Metab. Dispos. 26 (1998) 838-847
9. Papakonstantinou-Garoufalias S., Tani E., Todoulou O., Papadaki-Valiraki A., Philip-Patos E., and De Clercq E. J. Pharm. Pharmacol. 50 (1998) 117-124
10. Al-Soud Y.A., Al-Dweri M.N., and Al-Masoudi N.A. Il Farmaco 59 (2004) 775-783
11. Almasirad A., Tabatabai S.A., Faizi M., Kebriaeezadeh A., Mehrabi N., Dalvandi A., and Shafiee A. Bioorg. Med. Chem. Lett. 14 (2004) 6057-6059
12. Kritsanida M., Mouroutsou A., Marakos P., Pouli N., Papakonstantinou-Garoufalias S., Pannecouque C., Witvouw M., and De Clercq E. Il Farmaco 57 (2002) 253-257
13. Holla B.S., Poojary K.N., Rao B.S., and Shivananda M.K. Eur. J. Med. Chem. 37 (2002) 511-517
14. Holla B.S., Veerendra B., Shivananda M.K., and Boja P. Eur. J. Med. Chem. 38 (2003) 759-767
15. Al-Soud Y.A., Al-Masoudi N.A., and Ferwanah A.R.S. Bioorg. Med. Chem. 11 (2003) 1701-1708
16. Demirbas N., Ugurluoglu R., and Demirbas A. Bioorg. Med. Chem. 10 (2002) 3717-3721
17. Ikizler A.A., Uzunali E., and Demirbas A. Indian J. Pharm. 5 (2000) 289-292
18. Demirbas N., and Ugurluoglu R. Turk. J. Chem. 28 (2004) 679-690
19. Holla B.S., Sarojini B.K., Akberali P.M., Kumari N.S., and Shatty V. Il Farmaco 56 (2001) 565-570
20. Goss P.E., and Strasser-Weippl K. Best Pract. Res. Clin. Endocrinol. Metab. 18 (2004) 113-130
21. Santen J.R. Steroids 68 (2003) 559-567
22. Clemons M., Coleman R.E., and Verma S. Cancer Treat. Rev. 30 (2004) 325-332
23. Wawrzycka I., Kozioł A.E., and Galewicz-Walesa K. Z. Kristallogr. 215 (2000) 766-770
24. Allen F.H. Acta Crystallogr. B58 (2002) 380-388
25. Cambridge Structural Database. Ver. 5.29 (2007)
26. Beyer H., and Liebenow W. Chem. Ber. 90 (1957) 1738-1744
27. Sheldrick G.M. SHELXS97: Program for a Crystal Structure Solution (1997), University of Göttingen, Göttingen, Germany
28. Sheldrick G.M. SHELXL97: Program for the Refinement of a Crystal Structure from Diffraction Data (1997), University of Göttingen, Göttingen, Germany